DermaSensor

Maker of an FDA-cleared handheld AI device using elastic scattering spectroscopy to evaluate skin lesions for skin cancer in primary care.

Focus Areas

healthtech

Stage

private

Funding

$16MSeries BOct 2, 2025

Investors

Healthtech CapitalLSPPier 70 VenturesKern Venture GroupGenHenn Capital
#healthtech#south-florida#miami

Quick Info

๐Ÿ“Miami, FL
๐Ÿ“…Founded 2009
๐Ÿ’ฐRaised: $16M (Series B)

Need a warm intro?

Trace Cohen has 65+ investments and deep relationships across South Florida. Reach out for a direct connection.

Request Intro โ†’ t@nyvp.com